TREA

79396488 - ATON

Follow

Information

  • Trademark
  • 79396488
  • Serial Number
    79396488
  • Registration Number
    7749376
  • Filing Date
    December 08, 2023
    a year ago
  • Registration Date
    April 08, 2025
    a month ago
  • Transaction Date
    April 08, 2025
    a month ago
  • Status Date
    April 08, 2025
    a month ago
  • Published for Opposition Date
    February 18, 2025
    3 months ago
  • Location Date
    April 07, 2025
    a month ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    HUSSAIN, TASNEEM
  • Attorney Docket Number
    T72469
    Attorney Name
    Jeffrey H. Handelsman
  • Owners
Information
Mark Drawing Code
4
Mark Identification
ATON
Case File Statements
  • GS0051: Pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical pharmaceutical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; veterinary products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; sanitary sterilizing preparations; chemical preparations for pharmaceutical use for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; pharmaceutical products for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological, biochemical and biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for human use; medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use, remedies for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for veterinary use; stem cells for medical use; stem cells for veterinary use; biological tissue cultures for medical use; biological tissue cultures for veterinary use; cultures of micro-organisms for medical use; skin grafts being living tissues; surgical implants made of living tissue; antibodies; diagnostic preparations for medical use; diagnostic preparations for veterinary use; in-vitro diagnostic preparations for medical use; biotechnological preparations for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes for medical use; chemical reagents for medical and veterinary use; diagnostic biomarking reagents for medical use; antibiotics
  • GS0011: Chemical products, namely, chemical additives, chemical active ingredients, chemical solvents, chemical reagents, chemical preservatives, chemical antioxidants, ethylene oxide, ethylene glycol, chlorine for use in the manufacture of pharmaceuticals; active chemical ingredients intended for the manufacture of medicines for treating viral and infectious diseases, cancer, neurodegenerative diseases, obesity and diabetes; biological preparations other than for medical or veterinary use; biological tissue cultures other than for medical or veterinary purposes; cultures of microorganisms other than for medical or veterinary use; stem cells other than for medical or veterinary use; protein being raw material for scientific and medical research; vitamins for manufacturing pharmaceutical products; chemical reagents other than for medical or veterinary use; diagnostic reagents for in-vitro use in biochemistry, clinical chemistry and microbiology other than for medical use; chemical reagents for developing monoclonal antibodies other than for medical or veterinary use; monoclonal antibodies for diagnostic use, namely, for scientific purposes other than medical; monoclonal antibodies for industrial scientific research use; chemical substances for analyses in laboratories, other than for medical or veterinary purposes intended for the biotechnology industry
  • GS0421: Scientific and industrial research and development of vaccines and medicines; engineering; product research and development in industrial processes; product research and development concerning the automation of industrial processes; surveying, namely, engineering work; biological research; medical research; chemical research; scientific laboratory services; laboratory services for medical research; scientific laboratory services for studies, research and analysis in the field of chemistry and biology; scientific and technological research relating to patent mapping; research and development in the field of antibodies; research and development in the field of microorganisms and cells; research and development in the field of biochemistry and biotechnology; information about scientific research in the field of biochemistry and biotechnology; technological consultancy services in the technology field of biotechnology and medical technologies; scientific research in the nature of conducting clinical trials for others; testing of materials; scientific and industrial research, fine tuning industrial processes, namely, troubleshooting of industrial process control computer software problems, data automation using proprietary software to evaluate, analyze and collect service data, professional scientific consultancy, material testing, scientific laboratory services, and computer programming, all these services being dedicated to biology, bioinformatics, biochemistry, biotechnology, pharmacy, proteomics, genomics, cosmetics and agronomy; industrial and scientific research services in the field of molecular biology and more specifically genomics, proteomics, protein screening and protein interaction research; scientific research and analysis in the field of genetics and genetic engineering and in the field of chemical reagents; research and development of new products for third parties; development and maintenance of computer platforms in the field of the pharmaceutical industry and biotechnology; computer platform as a service [PaaS] featuring software for scientific analysis and research in the field of the pharmaceutical industry and biotechnology; software engineering services for data processing in the field of the pharmaceutical industry and biotechnology; computer programming services for data processing in the field of the pharmaceutical industry and biotechnology; developing and hosting databases in the field of the pharmaceutical industry and biotechnology; scientific data analysis in the field of the pharmaceutical industry and biotechnology; electronic storage of data in the field of the pharmaceutical industry and biotechnology; engineering services for developing computer data banks in the field of the pharmaceutical industry and biotechnology; developing and providing online non-downloadable computer software platforms for scientific analysis and research and antibody data bank, namely, data warehousing
Case File Event Statements
  • 5/30/2024 - 12 months ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 6/1/2024 - 12 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 7/9/2024 - 10 months ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/11/2024 - 10 months ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 8/2/2024 - 9 months ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/1/2024 - 12 months ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 7/10/2024 - 10 months ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 1/27/2025 - 4 months ago
    17 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/27/2025 - 4 months ago
    18 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/27/2025 - 4 months ago
    10 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 8/2/2024 - 9 months ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 8/25/2024 - 9 months ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 1/27/2025 - 4 months ago
    12 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 1/27/2025 - 4 months ago
    15 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 1/27/2025 - 4 months ago
    14 - TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS Type: ECDR
  • 1/27/2025 - 4 months ago
    13 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 1/27/2025 - 4 months ago
    11 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 1/27/2025 - 4 months ago
    16 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/29/2025 - 3 months ago
    19 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/12/2025 - 3 months ago
    20 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 2/18/2025 - 3 months ago
    21 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 2/18/2025 - 3 months ago
    22 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 4/8/2025 - a month ago
    23 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 4/8/2025 - a month ago
    24 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC